SCHOTT Pharma AG & Co. KGaA (BIT:1SXP)
Italy · Delayed Price · Currency is EUR 15.08
-0.30 (-1.95%)
Last updated: Dec 12, 2025, 9:00 AM CET
BIT:1SXP Revenue
In the fiscal year ending September 30, 2025, SCHOTT Pharma AG & Co. KGaA had annual revenue of 986.21M EUR with 3.04% growth. SCHOTT Pharma AG & Co. KGaA had revenue of 247.58M in the quarter ending September 30, 2025, with 4.44% growth.
Revenue
986.21M
Revenue Growth
+3.04%
P/S Ratio
2.31
Revenue / Employee
206.54K
Employees
4,690
Market Cap
2.28B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Sep 30, 2025 | 986.21M | 29.12M | 3.04% |
| Sep 30, 2024 | 957.09M | 58.49M | 6.51% |
| Sep 30, 2023 | 898.60M | 77.46M | 9.43% |
| Sep 30, 2022 | 821.14M | 172.48M | 26.59% |
| Sep 30, 2021 | 648.67M | 64.44M | 11.03% |
| Sep 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Stellantis | 146.12B |
| Eni S.p.A. | 86.56B |
| Enel SpA | 77.78B |
| Assicurazioni Generali | 56.79B |
| Intesa Sanpaolo | 25.32B |
| UniCredit | 24.85B |
| Prysmian | 19.49B |
| Leonardo S.p.a. | 19.13B |